Cambridge Prostate Cancer logo

Cambridge Prognostic Groups
for non-metastatic newly diagnosed prostate cancer

Yes  |  No  |  Not yet known

The Cambridge Prognostic Group (CPG) system is recommended by the National Institute of Health and Care Excellence (NICE) for classifying men with a new diagnosis of prostate cancer. This website is designed to help derive an individual’s CPG group to help in clinical management.

Please see here for more details on the NICE recommendations: NICE National Institute for Health and Care Excellence logo